Correlation of Objective Ocular Alignment and Subjective Diplopia After Teprotumumab in Patients With Thyroid Eye Disease (TED)

Identifier 20240305_nanos_posters_443
Title Correlation of Objective Ocular Alignment and Subjective Diplopia After Teprotumumab in Patients With Thyroid Eye Disease (TED)
Creator Tejus Pradeep; Taylor Linaburg; Cory Shoshany; Clare Teng; Kevin Zhang; Yuanyuan Chen; Cesar Briceno; Madhura Tamhankar
Affiliation (TP) (CS) (CT) (KZ) (YC) Scheie Eye Institute/University of Pennsylvania; (CB) Scheie Eye Institute, University of Pennsylvania; (MT) Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA
Subject Graves' Disease; Ocular Motility; Orbit
Description Teprotumumab, an insulin-like growth factor one (IGF-1) antagonist improved proptosis and diplopia in patients with thyroid eye disease (TED). Prior clinical trials documented subjective improvement in diplopia in study subjects who received teprotumumab, but have not documented objective measurements of ocular alignment. We sought to objectively measure ocular misalignment in TED patients with diplopia who received teprotumumab.
Date 2024-03
References None provided.
Language eng
Format application/pdf
Type Text
Source 2024 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2024: Poster Session: Analytical Studies: Ocular Motility Disorders and Nystagmus
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2024. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6d1bcwh
Setname ehsl_novel_nam
ID 2594270
Reference URL https://collections.lib.utah.edu/ark:/87278/s6d1bcwh
Back to Search Results